Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study

This study has been completed.
Sponsor:
Information provided by:
Logan College of Chiropractic
ClinicalTrials.gov Identifier:
NCT00343590
First received: June 21, 2006
Last updated: October 16, 2008
Last verified: October 2008
  Purpose

The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in a participant with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.


Condition Intervention
Multiple Sclerosis
Device: Whole Body Vibration machine

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study

Resource links provided by NLM:


Further study details as provided by Logan College of Chiropractic:

Primary Outcome Measures:
  • NeuroCom Balance Master
  • SF-EMG Nerve conduction velocity test
  • Berg balance score

Study Start Date: June 2006
Study Completion Date: November 2006
Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   25 Years to 65 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)

Exclusion Criteria:

1)visual or vestibular condition that would affect balance; 2) Non-Ms related systemic illness that would have an adverse effect on balance; 3) Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes; 4) Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates; 5) Acute thrombosis; 6) Severe migraine, epilepsy; 7) Serious cardiovascular disease, wearing a pacemaker; Any Spinal manipulation within 48 hours; 8) Acute disc herniation, discopathy or spondylolysis; 9) Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance; 10) Any implanted device or prosthesis or intrauterine IUD type of device; 11) Pregnancy

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00343590

Locations
United States, Missouri
Logan College of Chirpractic
Chesterfield, Missouri, United States, 63017
Logan College of Chiropractic
Chesterfield, Missouri, United States, 63017
Sponsors and Collaborators
Logan College of Chiropractic
Investigators
Principal Investigator: Dennis Enix, DC Logan College of Chiropractic
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00343590     History of Changes
Other Study ID Numbers: LCC-06-03
Study First Received: June 21, 2006
Last Updated: October 16, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Multiple Sclerosis
Sclerosis
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on August 21, 2014